Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip OA

Osteoarthritis Treatments: Monoclonal Antibody Starts Clinical Trial & Fasinumab Promising for Treating Pain

Michele B. Kaufman, PharmD, BCGP  |  May 25, 2016

Recent clinical trials have evaluated the efficacy of GSK3196165, a monoclonal antibody, and fasinumab, a nerve growth factor antibody, in treating patients with osteoarthritis and pain…

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:fasinumabhandhand painKnee Osteoarthritis (OA)monoclonal antibodyosteoarthritis (OA)Pain

Preparing for Increased HIPAA Audits Among Smaller Rheumatology Providers

Steven M. Harris, Esq.  |  May 13, 2016

Recent enforcement activities of the Department of Health and Human Services’ Office for Civil Rights (OCR) have shown an increase in fines and penalties assessed against smaller providers for failing to comply with the privacy, security and breach notification requirements of the Health Insurance Portability and Accountability Act (HIPAA). Historically, OCR has focused on larger…

Filed under:Billing/CodingLegal UpdatesPractice Support Tagged with:AuditsHHSHIPAA complianceLegalnoncompliancephysician practicePractice Managementrheumatologist

Phase 2 of HIPAA Audit Program Launches

From the College  |  May 13, 2016

With many competing priorities facing physician practices, HIPAA compliance and security is not a topic that usually makes it to the top of the list. But this is not the case with the Department of Health and Human Services’ Office for Civil Rights (OCR), because it has initiated a new phase of audits of physician…

Filed under:From the CollegePractice Support Tagged with:ComplianceGuidelinesHIPAA auditPracticeRegulationrheumatologistSecurity

Researchers Work to Untangle the Relationship Between Blood Lipids, Bone Health & Diet

Lara C. Pullen, PhD  |  May 2, 2016

A recent editorial examined research findings on how low levels of high-density lipoprotein (HDL) in the blood affect bone health, resulting in cartilage dysfunction and the development of osteoarthritis (OA). Authors note that a high-fat diet in mice with HDL deficiency resulted in OA development; thus, they conclude that in patients with metabolic syndrome, HDL may have a causative relationship to OA…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:bonebone lossDietlipidsosteoarthritis (OA)Osteoporosis

From the Expert: Dr. Anne Bass Addresses Fellowship Training in Rheumatology

Richard Quinn  |  April 29, 2016

As the need for specialists increases, the Rheumatology Fellowship Program at HHS seeks to grow the number of practicing rheumatologists. Program Director Anne Bass, MD, discusses the program’s ideas behind funding rheumatology fellowships and the challenges of attracting medical students to the field…

Filed under:Career DevelopmentEducation & TrainingProfessional Topics Tagged with:FellowsfellowshipHospital for Special Surgery in New YorkrheumatologistrheumatologyRheumatology Fellowship ProgramTraining

Medicare Access and CHIP Reauthorization Act of 2015: What You Should Know

Joan M. Von Feldt, MD, MSEd, FACR, FACP  |  April 15, 2016

There is no denying that the past few years have been a time of immense change in healthcare. Sweeping pieces of legislation have fundamentally altered the way we practice medicine. This is absolutely the case when it comes to the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA, for short). MACRA is an enormous…

Filed under:Billing/CodingLegislation & AdvocacyPractice SupportPresident's PerspectiveTechnology Tagged with:AC&RAmerican College of Rheumatology (ACR)MACRAMedicare Access and CHIP Reauthorization ActphysicianPractice ManagementReimbursementrheumatologistSGRsustainable growth rate formula

Mediterranean Diet Tied to Lower Hip Fracture Risk

Andrew M. Seaman  |  March 29, 2016

(Reuters Health)—Women who maintain an overall healthy diet may benefit from a slightly reduced risk of hip fractures later in life, according to a new U.S. study. Women who followed a Mediterranean-style diet were about three tenths of a percent less likely to break a hip over about 16 years, compared to women who didn’t…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:DieteatingFractureshiphip fracturehip fracture riskMediterranean dietOsteoporosis

Rheumatology Drug Updates: Opioid CR845 for OA Pain; RA Treatments in Development

Michele B. Kaufman, PharmD, BCGP  |  March 15, 2016

CR845—an oral, peripherally selective kappa opioid agonist—is currently in Phase 2 trials for the treatment of pruritus, and acute and chronic pain.1 Eighty patients with hip osteoarthritis (OA) or knee OA were randomized to receive treatment with 0.25 mg, 0.5 mg, 1.0 mg or 5.0 mg CR845 twice daily for two weeks. Safety assessment, pharmacokinetics…

Filed under:AnalgesicsConditionsDrug UpdatesRheumatoid Arthritis Tagged with:drugFDAopioidOsteoarthritisPainRheumatoid arthritisrheumatologySafetytrial

2015 ACR/ARHP Annual Meeting: Genetic Links Emerge in Osteoarthritis

Thomas R. Collins  |  March 15, 2016

SAN FRANCISCO—As researchers have delved into the genetics behind osteoarthritis (OA), genes that appear to be players in the disease have emerged, but there have also been curveballs thrown, with expectations not always matching up to the genetic realities, an expert said at the 2015 ACR/ARHP Annual Meeting. The genetic risk of acquiring OA is…

Filed under:ConditionsMeeting ReportsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:2015 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)geneticslinkOsteoarthritisResearch

Gut-on-a-Chip Provides Insight into Microbiome & Intestinal Inflammation

Lara C. Pullen, PhD  |  February 8, 2016

Researchers have created a microdevice with Caco-2 intestinal epithelial cells to aid in studying the human gut microbiome’s role in homeostasis, immune modulation and pathology. Using this gut-on-a-chip, researchers were able to examine in detail the processes they think result in chronic intestinal inflammation…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:gut microbiomeinflammatory bowel diseaseMicrobiomepathology

  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 329
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences